MFN2 and cancer: Conversely, the fusion protein MFN2 has been implicated in regulating angiogenesis and metastasis in cancers; notably, MFN2 overexpression in endothelial cells suppresses angiogenesis by downregulating proangiogenic factors [182, 183].